Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cochlear Limited
  6. Summary
    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
234.87 236.48 236.03 237.04 225.73 Last
66858 96692 75775 97634 173670 Volume
-1.43% +0.69% -0.19% +0.43% -4.77% Change
Estimated financial data (e)
Sales 2022 1 662 M 1 205 M 1 205 M
Net income 2022 280 M 203 M 203 M
Net cash position 2022 559 M 405 M 405 M
P/E ratio 2022 53,2x
Yield 2022 1,35%
Sales 2023 1 842 M 1 335 M 1 335 M
Net income 2023 323 M 234 M 234 M
Net cash position 2023 618 M 448 M 448 M
P/E ratio 2023 46,1x
Yield 2023 1,59%
Capitalization 14 850 M 10 761 M 10 761 M
EV / Sales 2022 8,60x
EV / Sales 2023 7,72x
Nbr of Employees 4 000
Free-Float 99,6%
More Financials
Company
Cochlear Limited is an Australian-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three geographical segments: Americas, EMEA and Asia Pacific. Its products offer various ways to hear, such as automatically adjusting hearing to different environments and streaming sound from a smartphone. It... 
More about the company
Ratings of Cochlear Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about COCHLEAR LIMITED
03:04aCOCHLEAR : Faces Patent Infringement Complaint in US
MT
09/23COCHLEAR LIMITED : Ex-dividend day for final dividend
FA
09/22COCHLEAR : Foundation launches global partnership with Malala Fund to remove hearing loss ..
PU
09/14SONOVA INVESTOR & ANALYST DAY 2021 : Entering a new phase from a position of strength
DJ
09/08SENSORION : Cochlear to Start Pilot Study of Hearing Preservation Drug
MT
09/08Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservati..
CI
08/23COCHLEAR : Hearing Health Today podcast set for return after 4,000+ tune in
PU
08/19Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022
CI
08/19Cochlear Limited Declares Ordinary Fully Paid Dividend for the Six Months Ended June 30..
CI
07/19Cochlear Limited Announces Board Changes
CI
07/15EQS-ADHOC : Sonova to strengthen business unit leadership on the Management Board
DJ
07/07Australian shares close at 2-week high on IT, health stocks boost
RE
05/31COCHLEAR : Promotes Non-Executive Director to Chairman
MT
05/31Cochlear Limited Announces Executive Changes
CI
05/14APPLIED GENETIC TECHNOLOGIES : Otonomy's OTO-825 Gene Therapy Saves Hearing Loss in Precli..
MT
More news
News in other languages on COCHLEAR LIMITED
03:04aCochlear fait l'objet d'une plainte pour violation de brevet aux États-Unis
09/08SENSORION : début des essais sur un candidat-médicament
09/08Sensorion et Cochlear vont lancer une étude pilote sur un médicament destiné à préserve..
08/20MÄRKTE ASIEN/Talfahrt in Hongkong geht weiter - Autoaktien stark unter Druck
08/20MÄRKTE ASIEN/Rasante Talfahrt in Hongkong geht weiter
More news
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | MarketScreener
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 225,73 AUD
Average target price 225,66 AUD
Spread / Average Target -0,03%
EPS Revisions
Managers and Directors
Diggory William Howitt President, CEO, Executive Director & MD
Stuart Sayers Chief Financial Officer & President-Services
Catriona Alison Deans Chairman
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COCHLEAR LIMITED19.43%11 376
STRAUMANN HOLDING AG87.35%33 269
SONOVA HOLDING AG67.17%26 288
DEMANT A/S50.87%13 713
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.51.46%4 265
ÖSSUR HF.-5.47%3 052